NDC 76420-056 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC76420-056

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Asclemed USA, Inc.
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (6)

Package NDCDescriptionSince
76420-056-044 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (76420-056-04)Oct 29, 2020
76420-056-066 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (76420-056-06)Aug 29, 2020
76420-056-088 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (76420-056-08)Aug 28, 2026
76420-056-1010 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (76420-056-10)Feb 5, 2020
76420-056-2020 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (76420-056-20)Feb 5, 2020
76420-056-3030 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (76420-056-30)Feb 5, 2020

Other Ondansetron products